Keyphrases
Gut Microbiota
100%
Hypoglycemic Activity
100%
Astragalus Membranaceus
100%
Db Mouse
100%
Type 2 Diabetes Mellitus (T2DM)
42%
Diabetic
28%
Glucagon-like
28%
Fecal Short-chain Fatty Acids
28%
Intestinal Integrity
28%
Therapeutic Strategies
14%
Alleviation
14%
Mechanistic Studies
14%
Short-chain Fatty Acids
14%
Relative Abundance
14%
Pearson Correlation Analysis
14%
Zonula occludens-1 (ZO-1)
14%
Gut Microbial Community
14%
Tight Junction Proteins
14%
Days of Treatment
14%
Akkermansia
14%
Herbal Polysaccharides
14%
Short-chain Fatty Acids Production
14%
Gut Microbiota Regulation
14%
Intestinal Bacteria
14%
G Protein-coupled Receptor 41
14%
Pharmacology, Toxicology and Pharmaceutical Science
Polysaccharide
100%
Intestine Flora
100%
Antidiabetic Agent
100%
Astragalus membranaceus
100%
Db/Db Mouse
100%
Short Chain Fatty Acid
37%
Non Insulin Dependent Diabetes Mellitus
37%
Diabetes Mellitus
25%
Glucagon-Like Peptide-1
25%
G Protein Coupled Receptor
12%
Acid
12%
Tight Junction Protein
12%
Medicine and Dentistry
Gut Microbiota
100%
Polysaccharide
100%
Antidiabetic Activity
100%
Astragalus
100%
Maturity Onset Diabetes of the Young
37%
Short Chain Fatty Acid
37%
Secretion (Process)
25%
Diabetes Mellitus
25%
Glucagon Like Peptide 1
25%
G Protein Coupled Receptor
12%
Acid
12%
Tight Junction Protein
12%
Akkermansia
12%
Immunology and Microbiology
Intestine Flora
100%
Astragalus membranaceus
100%
Db/Db Mouse
100%
Antidiabetic Activity
100%
Secretion (Process)
28%
Glucagon-Like Peptide-1
28%
Tight Junction
14%
Akkermansia
14%